Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 21 December 2025

Strategy Inc (MSTR) Stock: Week-Ahead Outlook for Dec. 22–26, 2025 as Bitcoin Buys, Index Risk, and Holiday Trading Collide

Strategy Inc (MSTR) Stock: Week-Ahead Outlook for Dec. 22–26, 2025 as Bitcoin Buys, Index Risk, and Holiday Trading Collide

Strategy Inc. (Nasdaq: MSTR)—the company formerly known as MicroStrategy—heads into the Christmas-shortened trading week with investors focused less on its legacy software business and more on three immediate drivers: bitcoin price direction, index-provider scrutiny, and the company’s ongoing capital-raising machine that funds more BTC purchases. Yahoo Finance+2SEC+2 As of the latest available quote, MSTR was at $164.82 (last reported trade after Friday’s session), a level that underscores how quickly sentiment can swing when bitcoin volatility meets thin holiday liquidity. Below is what matters most for the week ahead (Dec. 22–26, 2025)—including the latest confirmed bitcoin-buy updates, fresh credit commentary, major
21 December 2025
·····
Rocket Lab Stock (RKLB) Week Ahead: Record Close After $816M Space Force Satellite Deal—Catalysts, Forecasts, and Key Risks to Watch

Rocket Lab Stock (RKLB) Week Ahead: Record Close After $816M Space Force Satellite Deal—Catalysts, Forecasts, and Key Risks to Watch

As of Sunday, December 21, 2025, Rocket Lab Corporation stock (NASDAQ: RKLB) is heading into a holiday-shortened trading week after a stunning two-day surge that pushed shares to a record close of $70.52 on Friday, December 19. The rally has been fueled by a major U.S. national-security satellite award—Rocket Lab’s largest contract to date—alongside fresh launch momentum that capped off a milestone year for its Electron rocket. StockAnalysis+2MarketWatch+2 What happens next may depend less on headlines about “space hype” and more on whether Rocket Lab can convert a growing defense backlog into predictable manufacturing execution—while keeping investors confident in its
21 December 2025
·····
Warner Bros. Discovery (WBD) Stock Week Ahead: Netflix Deal vs. Paramount Tender Offer Keeps Shares in “Merger-Arbitrage Mode”

Warner Bros. Discovery (WBD) Stock Week Ahead: Netflix Deal vs. Paramount Tender Offer Keeps Shares in “Merger-Arbitrage Mode”

Dateline: December 21, 2025 (Week Ahead: Dec. 22–26, 2025) Warner Bros. Discovery, Inc. Series A stock (NASDAQ: WBD) heads into a holiday-shortened week with the kind of headline-driven volatility that rarely shows up in “normal” media earnings models. The reason is simple: WBD is now trading less like a traditional entertainment company and more like a live deal—anchored between two competing paths to a potential takeover. On Friday’s close, WBD finished around $27.77, putting it almost exactly on top of the $27.75 per-share headline value Netflix is pitching to WBD shareholders—while still leaving a meaningful gap to Paramount Skydance’s $30.00
21 December 2025
······
ServiceNow (NOW) Stock Week Ahead: Armis Deal Chatter, Moveworks Integration, 5-for-1 Split Fallout, and Fresh Analyst Targets

ServiceNow (NOW) Stock Week Ahead: Armis Deal Chatter, Moveworks Integration, 5-for-1 Split Fallout, and Fresh Analyst Targets

ServiceNow, Inc. (NYSE: NOW) heads into the week of December 22–26, 2025 with momentum in its product narrative—but also with headline risk that has recently dominated the stock. The company has closed its largest acquisition to date (Moveworks), announced a security-focused buyout of identity specialist Veza, and completed a 5-for-1 stock split—all while markets digest reports that ServiceNow is in advanced talks to buy cybersecurity firm Armis for up to $7 billion. Reuters+3ServiceNow Newsroom+3ServiceNow Newsroom+3 With U.S. markets entering a holiday-shortened, potentially low-liquidity week—and with macro data still on the calendar—ServiceNow stock could be especially sensitive to incremental headlines, analyst
21 December 2025
·····
Bank of America (BAC) Stock: Week-Ahead Outlook for Dec. 22–26, 2025 — Holiday Trading, Key Catalysts, and Fresh Analyst Forecasts

Bank of America (BAC) Stock: Week-Ahead Outlook for Dec. 22–26, 2025 — Holiday Trading, Key Catalysts, and Fresh Analyst Forecasts

Bank of America Corporation (NYSE: BAC) heads into the Christmas week with momentum from Friday’s rally—but also with cross-currents that could matter more than usual in a holiday-shortened, liquidity-thin tape. As of Sunday, December 21, 2025, U.S. equity markets are closed, so the most recent reference point is Friday’s close: BAC ended the session at $55.27, up 1.86% on the day. StockAnalysis That finish put the stock back near the upper end of its recent range and close to the year’s highs (52-week range roughly $33.07 to $56.07, depending on the data source). StockAnalysis+1 Below is what matters for BAC
21 December 2025
·····
Mastercard Stock (NYSE: MA) Week Ahead: Buyback Tailwinds, Legal Headlines, and Holiday Data Set the Tone for Dec. 22–26, 2025

Mastercard Stock (NYSE: MA) Week Ahead: Buyback Tailwinds, Legal Headlines, and Holiday Data Set the Tone for Dec. 22–26, 2025

Mastercard Incorporated (NYSE: MA) heads into the week of December 22–26, 2025 with a familiar mix of year-end catalysts: a holiday-shortened trading calendar, fresh legal and regulatory headlines across the payments ecosystem, and renewed focus on shareholder returns after Mastercard’s dividend hike and new buyback authorization earlier this month. NASDAQ Trader+2Reuters+2 For investors, this is less about a single “make-or-break” event and more about whether Mastercard stock can hold its recent momentum in a week where liquidity is typically thinner—and where headline risk can move mega-cap names faster than fundamentals do. Where Mastercard stock stands heading into Christmas week Mastercard
21 December 2025
···
Goldman Sachs (GS) Stock Week Ahead: AI Deal Push, ETF Expansion, and Holiday-Shortened Market Catalysts for Dec. 22–26, 2025

Goldman Sachs (GS) Stock Week Ahead: AI Deal Push, ETF Expansion, and Holiday-Shortened Market Catalysts for Dec. 22–26, 2025

As of Sunday, December 21, 2025, Goldman Sachs Group, Inc. (NYSE: GS) heads into the Christmas week trading window with its shares hovering near recent highs—after closing $893.48 on Friday, December 19, up 1.96% on the day. Yahoo Finance That positioning matters this week because trading conditions are likely to be unusually “thin” and headline-sensitive. U.S. markets are scheduled for an early close on Wednesday, Dec. 24 (1:00 p.m. ET) and a full close on Thursday, Dec. 25, before reopening for a regular session on Friday, Dec. 26—a setup that can amplify moves in large-cap financials like Goldman when liquidity
21 December 2025
·····
Citigroup stock week-ahead outlook: regulatory relief, a fresh 52-week high, and the key catalysts to watch in the Christmas-trading week

Citigroup stock week-ahead outlook: regulatory relief, a fresh 52-week high, and the key catalysts to watch in the Christmas-trading week

December 21, 2025 — Citigroup Inc. (NYSE: C) heads into the holiday-shortened week with renewed momentum after finishing Friday at $114.86, a fresh 52-week closing high, and extending a multi-day rally amid heavier-than-normal trading volume. MarketWatch But this isn’t just a year-end “Santa rally” story. Over the past week, Citi has benefited from a string of developments that investors have long wanted to see: incremental regulatory relief, visible progress on a multi-year transformation effort, and continued evidence that a healthier deal environment is feeding through into investment-banking fees. Reuters+2Reuters+2 With U.S. equity markets closing early on Wednesday, December 24, and
21 December 2025
····
AbbVie Stock Week Ahead (Dec. 22–26, 2025): ABBV Holds Near $227 as Drug-Pricing Headlines Collide With Fresh Analyst Upgrades

AbbVie Stock Week Ahead (Dec. 22–26, 2025): ABBV Holds Near $227 as Drug-Pricing Headlines Collide With Fresh Analyst Upgrades

As of Sunday, December 21, 2025, AbbVie Inc. (NYSE: ABBV) heads into a holiday-shortened trading week with shares hovering near the mid-$220s, after a high-volume rebound into Friday’s close. The setup for the week ahead is defined by two competing forces: strong underlying fundamentals (Skyrizi/Rinvoq momentum, updated 2025 outlook, and a higher dividend) and a renewed policy overhang as Washington accelerates its latest push to align U.S. drug prices with lower international benchmarks. Below is a practical, week-ahead roadmap of the latest news, forecasts, and market analysis investors are weighing right now. ABBV stock snapshot entering the week AbbVie shares
21 December 2025
·····
QUALCOMM Incorporated Stock (QCOM) Week Ahead: Alphawave Deal Closes Early, AI Data Center Push, and Holiday-Week Trading Setup (Dec 22–26, 2025)

QUALCOMM Incorporated Stock (QCOM) Week Ahead: Alphawave Deal Closes Early, AI Data Center Push, and Holiday-Week Trading Setup (Dec 22–26, 2025)

QUALCOMM Incorporated (NASDAQ: QCOM) heads into Christmas week with investors balancing two big narratives: a fresh, strategically important acquisition in data-center connectivity—and ongoing questions about the long-term shape of its handset business as Apple and broader smartphone demand evolve. Add a holiday-shortened trading week (and typically thinner liquidity), and the next few sessions could amplify both good news and bad. Qualcomm Investor Relations+2NYSE+2 Below is a week-ahead briefing (as of December 21, 2025) that pulls together the most relevant current news, forward-looking forecasts, and market-moving analyses shaping Qualcomm stock right now—plus a practical calendar of what to watch over the
21 December 2025
····
Amgen (AMGN) Stock Week Ahead Forecast: Drug-Price Deal Fallout, Analyst Targets, and Year-End Catalysts to Watch (Dec. 22–26, 2025)

Amgen (AMGN) Stock Week Ahead Forecast: Drug-Price Deal Fallout, Analyst Targets, and Year-End Catalysts to Watch (Dec. 22–26, 2025)

Amgen Inc. (NASDAQ: AMGN) heads into the Christmas-shortened trading week with a fresh wave of policy headlines, a newly expanded FDA label win in rare disease, and a market still laser-focused on what comes next for its obesity pipeline. Shares last traded around $327.38, following a session that ranged roughly between $323 and $331—levels that now matter even more in holiday-thinned liquidity. This coming week is also structurally different for U.S. equities: the NYSE closes early at 1:00 p.m. ET on Wednesday, Dec. 24, 2025 and is closed on Thursday, Dec. 25, 2025. That reduced time window can amplify single
21 December 2025
·····
Home Depot Stock (NYSE: HD) Week Ahead: 2026 Outlook, Analyst Targets, Technical Levels, and Key Catalysts for Dec. 22–26, 2025

Home Depot Stock (NYSE: HD) Week Ahead: 2026 Outlook, Analyst Targets, Technical Levels, and Key Catalysts for Dec. 22–26, 2025

Home Depot, Inc. (The) enters the Christmas-shortened trading week with Wall Street still digesting the company’s cautious preliminary fiscal 2026 outlook—and with investors watching whether housing data and interest-rate expectations can finally provide the “inflection” the home-improvement sector has been waiting for. HD shares last traded around $345 after Friday’s session (Dec. 19), and the stock has been volatile in December as the market recalibrates around slower recovery assumptions for big-ticket home projects. Investing.com Below is a week-ahead, Google News/Discover–ready briefing on the latest Home Depot news, forecasts, and market analysis as of Dec. 21, 2025, plus the catalysts that
21 December 2025
····
1 … 1,114 1,115 1,116 1,117 1,118 … 1,919

Stock Market Today

Meta stock faces an AI split: ad gains vs a $135 billion bill

Meta stock faces an AI split: ad gains vs a $135 billion bill

7 February 2026
Meta shares dropped 1.3% to $661.46 on Friday after the company projected 2026 capital spending of up to $135 billion, raising investor concerns over cash flow. Meta reported Q4 revenue of $59.89 billion, up 24% year-over-year, with ad impressions rising 18%. Analysts remain divided on whether AI-driven ad gains can offset the steep spending ramp.
Go toTop